Market Cap 5.95B
Revenue (ttm) 677.56M
Net Income (ttm) 59.01M
EPS (ttm) N/A
PE Ratio 78.85
Forward PE 55.69
Profit Margin 8.71%
Debt to Equity Ratio 0.00
Volume 576,500
Avg Vol 604,854
Day's Range N/A - N/A
Shares Out 78.02M
Stochastic %K 20%
Beta 0.09
Analysts Strong Sell
Price Target $98.00

Company Profile

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clin...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 44 78 1431 9100
Address:
105 Piccadilly, 2nd Floor, London, United Kingdom
Paperstocks89
Paperstocks89 Sep. 11 at 10:53 AM
$KNSA this screams buyout
0 · Reply
Paperstocks89
Paperstocks89 Sep. 10 at 10:31 PM
$KNSA hopefully your buying the dip before the news hits
0 · Reply
Paperstocks89
Paperstocks89 Sep. 10 at 1:50 PM
$KNSA the flag is set
0 · Reply
Paperstocks89
Paperstocks89 Sep. 9 at 11:33 PM
$KNSA massive new highs incoming
0 · Reply
Paperstocks89
Paperstocks89 Sep. 9 at 2:26 AM
$KNSA the news is about to hit
0 · Reply
Suppandi
Suppandi Sep. 7 at 8:51 PM
$CRDL Phase 3 trials are in motion…. The company with the only somewhat comparable drug on the market is $KNSA and it boasts a $6B market cap Just wondering and dreaming if we can get $60 price for this stock 💪💪💪
1 · Reply
StockConsultant
StockConsultant Sep. 4 at 2:00 AM
$KNSA Kiniksa Pharmaceuticals stock, watch for a bull flag breakout at https://www.stockconsultant.com/?KNSA Breakout trade WATCH for possible breakout above 81.35 Target: 88.69, 10.2% Stop: 78.16 Loss: 2.9% P/L ratio: 3.5 : 1 - Excellent BULLISH [Timing] Strong bullish 3 day candlestick pattern. [Timing] Breakout trade watch above 81.35, no resistance in area just above. BEARISH [Positioning] Intermediate trend possibly bearish, Uptrend turned sideways, may continue or pullback. [Positioning] at resistance
0 · Reply
Merlintrader
Merlintrader Sep. 1 at 1:08 PM
Kiniksa Pharmaceuticals ($KNSA) Stock Hub: Guidance Raised Twice In 2026, No Debt, And The Phase 3 That Has To Replace ARCALYST https://www.merlintrader.com/kiniksa-pharmaceuticals-stock-hub/
0 · Reply
FrostyOrbit
FrostyOrbit Aug. 30 at 10:08 PM
$KNSA Q2 revenue: $243.6M, +55% YoY; net income $25.4M...
0 · Reply
wizeinvesting
wizeinvesting Aug. 27 at 9:38 AM
$KNSA Getting investment income every week sounds simple—until you realize that most dividend-paying companies follow quarterly schedules that rarely line up neatly with your expenses. Trying to force a perfect payment calendar can easily lead you toward risky, high-yield investments. A better approach is to build the income stream around strong businesses, sustainable dividends, long-term growth, and strategic payment timing. When those pieces work together, your portfolio can start behaving less like a... https://www.wizeinvesting.com/p/what-happens-when-you-invest-500-a-month-in-knsa-for-5-years
0 · Reply
Latest News on KNSA
Kiniksa price target raised to $90 from $75 at Goldman Sachs

2026-07-30T10:17:03.000Z - 6 weeks ago

Kiniksa price target raised to $90 from $75 at Goldman Sachs


Kiniksa price target raised to $99 from $72 at Wedbush

2026-07-29T13:05:25.000Z - 6 weeks ago

Kiniksa price target raised to $99 from $72 at Wedbush


Kiniksa price target raised to $107 from $72 at JPMorgan

2026-07-29T12:03:41.000Z - 6 weeks ago

Kiniksa price target raised to $107 from $72 at JPMorgan


Kiniksa price target raised to $98 from $64 at Canaccord

2026-07-29T11:21:40.000Z - 6 weeks ago

Kiniksa price target raised to $98 from $64 at Canaccord


Kiniksa price target raised to $100 from $60 at Citi

2026-07-29T10:31:31.000Z - 6 weeks ago

Kiniksa price target raised to $100 from $60 at Citi


Kiniksa rises 23.9%

2026-07-28T16:05:56.000Z - 6 weeks ago

Kiniksa rises 23.9%


Kiniksa rises 22.7%

2026-07-28T14:05:53.000Z - 6 weeks ago

Kiniksa rises 22.7%


Kiniksa Pharmaceuticals International, Slides: Q2 2026

Jul 28, 2026, 8:30 AM EDT - 6 weeks ago

Kiniksa Pharmaceuticals International, Slides: Q2 2026


Kiniksa reports Q2 EPS 30c, consensus 28c

2026-07-28T11:45:31.000Z - 6 weeks ago

Kiniksa reports Q2 EPS 30c, consensus 28c


Kiniksa price target raised to $75 from $60 at Goldman Sachs

2026-07-23T10:06:16.000Z - 7 weeks ago

Kiniksa price target raised to $75 from $60 at Goldman Sachs


Kiniksa price target raised to $74 from $57 at Wells Fargo

2026-07-13T10:30:56.000Z - 2 months ago

Kiniksa price target raised to $74 from $57 at Wells Fargo


Kiniksa price target raised to $72 from $59 at Wedbush

2026-06-29T11:55:18.000Z - 2 months ago

Kiniksa price target raised to $72 from $59 at Wedbush


Kiniksa price target raised to $64 from $62 at Canaccord

2026-04-29T12:53:44.000Z - 4 months ago

Kiniksa price target raised to $64 from $62 at Canaccord


Kiniksa price target raised to $59 from $58 at Wedbush

2026-04-29T12:23:45.000Z - 4 months ago

Kiniksa price target raised to $59 from $58 at Wedbush


Kiniksa price target raised to $60 from $50 at Citi

2026-04-29T11:00:19.000Z - 4 months ago

Kiniksa price target raised to $60 from $50 at Citi


Kiniksa price target raised to $71 from $58 at Jefferies

2026-04-28T17:07:23.000Z - 4 months ago

Kiniksa price target raised to $71 from $58 at Jefferies


Kiniksa rises 19.3%

2026-04-28T16:06:33.000Z - 4 months ago

Kiniksa rises 19.3%


Kiniksa Pharmaceuticals International, Earnings release: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Kiniksa Pharmaceuticals International, Earnings release: Q1 2026


Kiniksa Pharmaceuticals International, Slides: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Kiniksa Pharmaceuticals International, Slides: Q1 2026


Kiniksa Pharmaceuticals International, Quarterly report: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Kiniksa Pharmaceuticals International, Quarterly report: Q1 2026


Kiniksa Pharmaceuticals International, Annual report: Q4 2025

Feb 24, 2026, 8:30 AM EST - 6 months ago

Kiniksa Pharmaceuticals International, Annual report: Q4 2025


Kiniksa Pharmaceuticals International, Earnings release: Q4 2025

Feb 24, 2026, 8:30 AM EST - 6 months ago

Kiniksa Pharmaceuticals International, Earnings release: Q4 2025


Kiniksa Pharmaceuticals International, Slides: Q4 2025

Feb 24, 2026, 8:30 AM EST - 6 months ago

Kiniksa Pharmaceuticals International, Slides: Q4 2025


Kiniksa Pharmaceuticals International, Annual report: Q4 2025

Feb 24, 2026, 8:30 AM EST - 6 months ago

Kiniksa Pharmaceuticals International, Annual report: Q4 2025


Kiniksa Pharmaceuticals Provides Corporate Update

Jan 12, 2026, 7:30 AM EST - 8 months ago

Kiniksa Pharmaceuticals Provides Corporate Update


Kiniksa Pharmaceuticals International, Slides: FY 2025

Nov 17, 2025, 9:30 AM EST - 9 months ago

Kiniksa Pharmaceuticals International, Slides: FY 2025


Kiniksa Pharmaceuticals International, Quarterly report: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 10 months ago

Kiniksa Pharmaceuticals International, Quarterly report: Q3 2025


Kiniksa Pharmaceuticals International, Earnings release: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 10 months ago

Kiniksa Pharmaceuticals International, Earnings release: Q3 2025


Kiniksa Pharmaceuticals International, Slides: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 10 months ago

Kiniksa Pharmaceuticals International, Slides: Q3 2025


Kiniksa Pharmaceuticals International, Slides: Q2 2025

Jul 29, 2025, 8:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals International, Slides: Q2 2025


Kiniksa Pharmaceuticals International, Slides: FY 2025

Jun 5, 2025, 12:50 PM EDT - 1 year ago

Kiniksa Pharmaceuticals International, Slides: FY 2025


Kiniksa Pharmaceuticals International, Slides: Q1 2025

Apr 29, 2025, 8:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals International, Slides: Q1 2025


Kiniksa Pharmaceuticals International, Annual report: Q4 2024

Feb 25, 2025, 8:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals International, Annual report: Q4 2024


Kiniksa Pharmaceuticals International, Slides: Q4 2024

Feb 25, 2025, 8:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals International, Slides: Q4 2024


Kiniksa Pharmaceuticals International, Slides: FY 2025

Jan 13, 2025, 4:30 PM EST - 1 year ago

Kiniksa Pharmaceuticals International, Slides: FY 2025


Kiniksa Pharmaceuticals International, Slides: Q3 2024

Oct 29, 2024, 8:30 AM EDT - 1 year ago

Kiniksa Pharmaceuticals International, Slides: Q3 2024


Kiniksa Pharmaceuticals International, Slides: Q2 2024

Jul 23, 2024, 8:30 AM EDT - 2 years ago

Kiniksa Pharmaceuticals International, Slides: Q2 2024


Kiniksa Pharmaceuticals International, Slides: Q1 2024

Apr 23, 2024, 8:30 AM EDT - 2 years ago

Kiniksa Pharmaceuticals International, Slides: Q1 2024


Kiniksa Pharmaceuticals International, Annual report: Q4 2023

Feb 28, 2024, 8:30 AM EST - 2 years ago

Kiniksa Pharmaceuticals International, Annual report: Q4 2023


Kiniksa Pharmaceuticals International, Slides: Q4 2023

Feb 28, 2024, 8:30 AM EST - 2 years ago

Kiniksa Pharmaceuticals International, Slides: Q4 2023


Kiniksa Pharmaceuticals International, Slides: FY 2024

Jan 8, 2024, 4:30 PM EST - 2 years ago

Kiniksa Pharmaceuticals International, Slides: FY 2024


Kiniksa Pharmaceuticals International, Slides: Q3 2023

Oct 31, 2023, 8:30 AM EDT - 2 years ago

Kiniksa Pharmaceuticals International, Slides: Q3 2023


Kiniksa Pharmaceuticals International, Slides: Q2 2023

Jul 25, 2023, 8:30 AM EDT - 3 years ago

Kiniksa Pharmaceuticals International, Slides: Q2 2023


Paperstocks89
Paperstocks89 Sep. 11 at 10:53 AM
$KNSA this screams buyout
0 · Reply
Paperstocks89
Paperstocks89 Sep. 10 at 10:31 PM
$KNSA hopefully your buying the dip before the news hits
0 · Reply
Paperstocks89
Paperstocks89 Sep. 10 at 1:50 PM
$KNSA the flag is set
0 · Reply
Paperstocks89
Paperstocks89 Sep. 9 at 11:33 PM
$KNSA massive new highs incoming
0 · Reply
Paperstocks89
Paperstocks89 Sep. 9 at 2:26 AM
$KNSA the news is about to hit
0 · Reply
Suppandi
Suppandi Sep. 7 at 8:51 PM
$CRDL Phase 3 trials are in motion…. The company with the only somewhat comparable drug on the market is $KNSA and it boasts a $6B market cap Just wondering and dreaming if we can get $60 price for this stock 💪💪💪
1 · Reply
StockConsultant
StockConsultant Sep. 4 at 2:00 AM
$KNSA Kiniksa Pharmaceuticals stock, watch for a bull flag breakout at https://www.stockconsultant.com/?KNSA Breakout trade WATCH for possible breakout above 81.35 Target: 88.69, 10.2% Stop: 78.16 Loss: 2.9% P/L ratio: 3.5 : 1 - Excellent BULLISH [Timing] Strong bullish 3 day candlestick pattern. [Timing] Breakout trade watch above 81.35, no resistance in area just above. BEARISH [Positioning] Intermediate trend possibly bearish, Uptrend turned sideways, may continue or pullback. [Positioning] at resistance
0 · Reply
Merlintrader
Merlintrader Sep. 1 at 1:08 PM
Kiniksa Pharmaceuticals ($KNSA) Stock Hub: Guidance Raised Twice In 2026, No Debt, And The Phase 3 That Has To Replace ARCALYST https://www.merlintrader.com/kiniksa-pharmaceuticals-stock-hub/
0 · Reply
FrostyOrbit
FrostyOrbit Aug. 30 at 10:08 PM
$KNSA Q2 revenue: $243.6M, +55% YoY; net income $25.4M...
0 · Reply
wizeinvesting
wizeinvesting Aug. 27 at 9:38 AM
$KNSA Getting investment income every week sounds simple—until you realize that most dividend-paying companies follow quarterly schedules that rarely line up neatly with your expenses. Trying to force a perfect payment calendar can easily lead you toward risky, high-yield investments. A better approach is to build the income stream around strong businesses, sustainable dividends, long-term growth, and strategic payment timing. When those pieces work together, your portfolio can start behaving less like a... https://www.wizeinvesting.com/p/what-happens-when-you-invest-500-a-month-in-knsa-for-5-years
0 · Reply
Paperstocks89
Paperstocks89 Aug. 26 at 5:56 PM
0 · Reply
Paperstocks89
Paperstocks89 Aug. 25 at 1:53 PM
$KNSA wait u til the news hits you will have wish you bought here
0 · Reply
Massimino
Massimino Aug. 25 at 7:15 AM
$KNSA this is ready to rip up again $100 soon
0 · Reply
Paperstocks89
Paperstocks89 Aug. 20 at 4:40 PM
$KNSA being sold for no reason anemic volume
0 · Reply
Paperstocks89
Paperstocks89 Aug. 19 at 11:52 PM
$KNSA you will wake up to this printing $125 one morning
0 · Reply
FiveMinute
FiveMinute Aug. 19 at 9:12 PM
$KNSA — Automated swing setup flagged tonight (8/19), new appearance. CONTINUATION setup, price +8.04% above EMA20. Fundamentals 55/100. Ref price: $80.80 Support: $60.06 | Resistance: $82.94 Invalidation: $76.76 Theoretical targets: $84.84 / $88.88 RSI: 68.2 (neutral-high) Status: EN OBSERVATION. Not financial advice.
0 · Reply
Paperstocks89
Paperstocks89 Aug. 19 at 3:58 PM
$KNSA how is this still sub $100
0 · Reply
findingthestock
findingthestock Aug. 11 at 3:13 AM
$ARDX Raab mismanagement has destroyed shareholders While other ceos are delivering $ARDX must learn an IR lesson from $KNSA on how to handle guidance. Regular beats & raises better than woolly long term goals & misses. Major difference in stock price trajectories & revenue multiples. IR is CEO level stuff. It is massively impactful.
1 · Reply
stockpicker63
stockpicker63 Aug. 1 at 5:12 AM
Weekly trading performance on the site! Top trades $KC +12%, $BLKB +10% , $KNSA +9.8% seel al trades on the site.
0 · Reply
Jaylan1
Jaylan1 Jul. 29 at 6:24 PM
$KNSA enough with the run
1 · Reply
Quantumup
Quantumup Jul. 29 at 2:02 PM
Wedbush⬆️ $KNSA's PT to $99 from $72 and reiterated at Outperform after KNSA reported positive recurrent pericarditis (RP) data for KPL-387 alongside a strong quarter. $CRDL VTYX - $LLY REGN NVS Wedbush continues to view KPL-387 as an important and de-risked life-cycle extension opportunity, w/ potential to reinforce KNSA's leadership in IL-1 blockade in RP while materially improving the long-term economic profile of the franchise.
0 · Reply
topstockalerts
topstockalerts Jul. 29 at 2:22 AM
$KNSA this is holding way too well to ignore
0 · Reply